Study on ONC201 for Treating Patients with Relapsed or Hard-to-Treat Acute Leukemia or High-Risk Myelodysplastic Syndrome | Clinical Trial

Study on ONC201 for Treating Patients with Relapsed or Hard-to-Treat Acute Leukemia or High-Risk Myelodysplastic Syndrome | Clinical Trial | Right2Hope